EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Serotonergic Regulation of Synaptic Dopamine Levels Mitigates L-DOPA-Induced Dyskinesia in a Mouse Model of Parkinson’s Disease

Yuan-Hao Chen, Tung-Tai Kuo, Vicki Wang, Pin-Wen Cheng, Eagle Yi-Kung Huang, Kuo-Hsing Ma, Nigel H Greig, Lars Olson, Barry J Hoffer, Kuan-Yin Tseng

Journal of Parkinson’s Disease · 23.07.2024 · 14 (5) · 941-964

DOI: 10.3233/jpd-240080 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Parkinson’s Disease, online erschienen am 18.06.2024. Verfasst von Yuan-Hao Chen und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurological Surgery, Tri-Service General Hospital, Taipei, Taiwan. Hauptthemen laut MEDLINE: Levodopa, Dyskinesia, Drug-Induced, Dopamine, Citalopram. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 65 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

The serotonin (5-HT) system can manipulate the processing of exogenous L-DOPA in the DA-denervated striatum, resulting in the modulation of L-DOPA-induced dyskinesia (LID).

Objective

To characterize the effects of the serotonin precursor 5-hydroxy-tryptophan (5-HTP) or the serotonin transporter (SERT) inhibitor, Citalopram on L-DOPA-induced behavior, neurochemical signals, and underlying protein expressions in an animal model of Parkinson’s disease.

Methods

MitoPark (MP) mice at 20 weeks of age, subjected to a 14-day administration of L-DOPA/Carbidopa, displayed dyskinesia, referred to as LID. Subsequent investigations explored the effects of 5-HT-modifying agents, such as 5-HTP and Citalopram, on abnormal involuntary movements (AIMs), locomotor activity, neurochemical signals, serotonin transporter activity, and protein expression in the DA-denervated striatum of LID MP mice.

Results

5-HTP exhibited duration-dependent suppressive effects on developing and established LID, especially related to abnormal limb movements observed in L-DOPA-primed MP mice. However, Citalopram, predominantly suppressed abnormal axial movement induced by L-DOPA in LID MP mice. We demonstrated that 5-HTP could decrease L-DOPA-upregulation of DA turnover rates while concurrently upregulating 5-HT metabolism. Additionally, 5-HTP was shown to reduce the expressions of p-ERK and p-DARPP-32 in the striatum of LID MP mice. The effect of Citalopram in alleviating LID development may be attributed to downregulation of SERT activity in the dorsal striatum of LID MP mice.

Conclusions

While both single injection of 5-HTP and Citalopram effectively mitigated the development of LID, the difference in mitigation of AIM subtypes may be linked to the unique effects of these two serotonergic agents on L-DOPA-derived DA and 5-HT metabolism.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

LevodopaDyskinesia, Drug-InducedDopamineCitalopramDisease Models, AnimalSerotoninAnimalsMiceSerotonin Plasma Membrane Transport Proteins5-HydroxytryptophanCorpus StriatumMaleSelective Serotonin Reuptake InhibitorsCarbidopaAntiparkinson AgentsParkinson Disease

Stichwörter der Autor:innen

5-HTPCitalopramL-DOPA-induced dyskinesiaParkinson’s diseaseSerotonin systemdopamine

Substanzen

LevodopaDopamineCitalopramSerotoninSerotonin Plasma Membrane Transport Proteins5-HydroxytryptophanSelective Serotonin Reuptake InhibitorsCarbidopaAntiparkinson Agents

Autor:innen und Institutionen

  • Department of Neurological Surgery, Tri-Service General Hospital, Taipei, Taiwan.
  • National Defense Medical Center, Taipei, Taiwan.
  • Department of Pharmacology, National Defense Medical Center, Taipei, Taiwan.
  • Doctoral Degree Program in Translational Medicine, National Defense Medical Center and Academia Sinica, Taipei, Taiwan.
  • Graduate Institute of Biology and Anatomy, National Defense Medical Center, Taipei, Taiwan.
  • Drug Design & Development Section, Translational Gerontology Branch, Intramural Research Program National Institute on Aging, National Institutes of Health (NIH), Baltimore, MD, USA.

Zitieren

APA

Chen, Y. H., Kuo, T. T., Wang, V., Cheng, P. W., Huang, E. Y., Ma, K. H., Greig, N. H., Olson, L., Hoffer, B. J., & Tseng, K. Y. (2024). Serotonergic Regulation of Synaptic Dopamine Levels Mitigates L-DOPA-Induced Dyskinesia in a Mouse Model of Parkinson’s Disease. Journal of Parkinson’s Disease, 14(5), 941-964. https://doi.org/10.3233/jpd-240080

Vancouver

Chen YH, Kuo TT, Wang V, Cheng PW, Huang EY, Ma KH, et al. Serotonergic Regulation of Synaptic Dopamine Levels Mitigates L-DOPA-Induced Dyskinesia in a Mouse Model of Parkinson’s Disease. Journal of Parkinson’s Disease. 2024;14(5):941-964. doi:10.3233/jpd-240080

BibTeX
@article{Chen2024,
  author = {Chen, Yuan-Hao and Kuo, Tung-Tai and Wang, Vicki and Cheng, Pin-Wen and Huang, Eagle Yi-Kung and Ma, Kuo-Hsing and Greig, Nigel H and Olson, Lars and Hoffer, Barry J and Tseng, Kuan-Yin},
  title = {Serotonergic Regulation of Synaptic Dopamine Levels Mitigates L-DOPA-Induced Dyskinesia in a Mouse Model of Parkinson’s Disease},
  journal = {Journal of Parkinson’s Disease},
  year = {2024},
  volume = {14},
  number = {5},
  pages = {941--964},
  doi = {10.3233/jpd-240080}
}
Kostenlos starten →